Search

everythinglearnresearchcommunity

for

Search:↓

Electrospun nanofibers show promise for enhancing blood vessel growth in tissue engineering but need further research to improve their effectiveness.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Some growth factors, while important for normal body functions, can cause diseases when not regulated properly.

Integrative hair therapy improved hair loss and regrowth.

Dihydrotestosterone (DHT) stops hair growth in mice by lowering a growth factor important for hair.

Finasteride lowers good cholesterol, raises bad fats, and may increase heart disease risk.

Certain steroids in the brain affect mood and symptoms of depression, and treatments targeting these steroids show promise for improving these symptoms.

Post-finasteride syndrome causes lasting sexual, neurological, and physical side effects in some people after taking finasteride.

Finasteride affects brain processes related to neurotransmission and metabolism, potentially helping with neuropsychiatric conditions.

Current research explores hair growth drugs, while future research aims for personalized treatments.

5α-Reductase inhibitors do not consistently increase testosterone levels in the blood.

Female mice with disrupted 5α-reductase 1 had significant metabolic issues, including stress response problems, insulin resistance, liver fat buildup, and obesity.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

Ganoderma lucidum, a type of mushroom, may help treat enlarged prostate by blocking testosterone conversion.

Finasteride affects brain and blood steroids, causing lasting sexual and emotional side effects.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

Certain drugs change freshwater snail shells to a "banana" shape.

Proscar (finasteride) blocks 5α-reductase in sea urchin ovaries and testes, suggesting potential treatment for androgen-related conditions.

A new method was created to test the effectiveness of Dihydrotestosterone (DHT) inhibitors, like finasteride and dutasteride, in human and fish cells. The results showed fish cells are more sensitive to these treatments, and dutasteride works better than finasteride in all tested cells.

Researchers developed a reliable way to measure hormones in urine, showing that a baldness treatment doesn't change hormone levels.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

New treatments for male hypogonadism are effective and should be personalized.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

SAHA syndrome is a condition in women involving skin and hair issues, often related to hormonal imbalances, and is treated based on the underlying cause.

Nanoparticles don't penetrate intact skin but can enter through pores or damaged skin.

The triterpenoids from Ganoderma lucidum can block testosterone effects and may help treat enlarged prostate.

Diane 35 plus finasteride is more effective for treating hirsutism.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Minoxidil helps grow longer, thicker hair in bald scalps of stumptailed macaques, and early treatment is more effective.